您现在的位置: 首页> 研究主题> 胸苷

胸苷

胸苷的相关文献在1982年到2022年内共计298篇,主要集中在肿瘤学、药学、特种医学 等领域,其中期刊论文78篇、会议论文2篇、专利文献218篇;相关期刊41种,包括生物工程学报、中成药、世界核心医学期刊文摘(妇产科学)等; 相关会议2种,包括第六届全国生物化工学术会议、全国催化学术会议等;胸苷的相关文献由722位作者贡献,包括夏颖、郑雄敏、王水淋等。

胸苷—发文量

期刊论文>

论文:78 占比:26.17%

会议论文>

论文:2 占比:0.67%

专利文献>

论文:218 占比:73.15%

总计:298篇

胸苷—发文趋势图

胸苷

-研究学者

  • 夏颖
  • 郑雄敏
  • 王水淋
  • 贾伟
  • 任祥万
  • 于金明
  • 叶婷
  • 蒋泉福
  • 陆春雄
  • 马丁
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 张勋; 张嘉嘉; 马迟; 邹福贤; 陈抒云; 黄泽豪; 林羽; 徐伟
    • 摘要: 目的:建立金线莲中12个核苷类成分(胞嘧啶、尿嘧啶、胞苷、鸟嘌呤、尿苷、腺嘌呤、肌苷、鸟苷、2'-脱氧鸟苷、β-胸苷、腺苷和2'-脱氧腺苷)含量的HPLC测定方法,并采用聚类分析法比较不同来源金线莲核苷类成分组成和含量差异.方法:采用Uitimate(R) XB-C18色谱柱(250 mm×4.6 mm,5μm),以甲醇(A)-水(B)为流动相,梯度洗脱,流速1.0 mL· min-1,检测波长260 nm,柱温30°C,进样量10 μL.采用聚类分析法评价不同批次金线莲中核苷类成分的化学模式.结果:12个核苷类成分质量浓度分别在考察的线性范围内与峰面积呈良好的线性关系(r>0.999 4);建立的方法精密度、重复性和稳定性良好;加样回收率为95.0%~114.6%(RSD≤4.8%).对52批金线莲样品中12个核苷类成分进行测定,其含量较高的主要为腺苷、尿苷、鸟苷、胞苷(均值大于300 μg·g-1),聚类分析发现不同来源金线莲核苷成分具有4类化学表型,含量之间存在差异.结论:建立的金线莲中12个核苷类成分的含量测定方法准确、可靠,可以为金线莲核苷类多指标质量控制体系提供新的技术手段.
    • 刘道佳; 吴君心; 唐明灯; 林端瑜; 张杰平; 李生栩; 蔡志华; 吕清湖
    • 摘要: 目的 探讨18F-脱氧胸腺嘧啶核苷(FLT) PET/CT显像中的肿瘤增殖体积(PV)在评估复发脑胶质瘤患者预后中的价值.方法 回顾性分析2012年1月至2016年1月行18F-FLT PET/CT与18F-氟脱氧葡萄糖(FDG) PET/CT检查、经病理结果或临床随访证实为复发的20例脑胶质瘤患者的临床资料.在18F-FLT PET/CT图像上测量复发肿瘤的最大标准化摄取值与正常脑组织的平均标准化摄取值的比值(T/NFLT)、最大直径和PV,在18F-FDG PET/CT图像上测量复发肿瘤的T/NFDG.随访时间截至2016年12月.采用Kaplan-Meier分析法进行生存分析,组间比较采用log-rank检验;采用比例风险回归(Cox)模型对PV、最大直径、T/NFDG、T/NLT及其他相关临床因素与预后关系进行单因素和多因素分析.结果 20例复发脑胶质瘤患者的中位生存时间为7个月.PV、T/NFLT、最大直径、T/NFDG、年龄预测长生存期的最佳阈值分别为12.565 cm3、7.752、2.800 cm、1.192、52岁,对应的ROC曲线下面积(AUC)分别为0.958、0.865、0.745、0.646、0.667.Kaplan-Meier单因素分析结果显示,复发灶不同PV(<12.565 cm3与≥12.565 cm3)、T/NFLT(<7.752与≥7.752)、肿瘤最大直径(<2.800 cm与≥2.800 cm)、T/NFDG(<1.192与≥1.192)、首次病理结果(Ⅱ级与Ⅲ、Ⅳ级)间的生存曲线差异均有统计学意义(x2 =12.587、12.219、4.285、5.955、6.787,均P<0.05).Cox模型单因素分析结果显示,20例复发脑胶质瘤患者的预后与PV、T/NFLT、T/NFDG、首次病理结果有关,危险比分别为0.113(95%CI:0.024~0.530)、0.105(95%CI:0.021~0.513)、0.314(95%CI:0.109~0.903)、0.262(95%CI:0.082~0.838),差异均有统计学意义(均P<0.05).Cox回归模型多因素分析结果显示,肿瘤PV是复发脑胶质瘤患者生存预后的独立影响因素.结论 18F-FLT PET/CT显像中的肿瘤PV可以作为复发脑胶质瘤患者预后的评估指标.%Objectives To evaluate the prognostic value of proliferation volume(PV) measured by pretreating patients with recurrent gliomas with 18F-fluorothymidine (FLT) PET/CT imaging.Methods The clinical data of 20 patients that underwent 18F-FDG PET/CT and 18F-FLT PET/CT examinations from January 2012 to January 2016 showed that recurrent gliomas were retrospectively analyzed.We measured the ratio of the maximum standard uptake value of the tumor to the mean standard uptake value of the normal brain tissue(T/NFLT),PV,and maximum diameter via 18F-FLT PET/CT imaging,T/NFDG was measured by 18F-FDG PET/CT imaging.The follow-up time lasted until December 2016.Result The median survival time of 20 patients with recurrent gliomas was 7 months.The optimal PV,T/NFLT,diameter,T/NFDG,and age cut-off values were 12.565 cm3,7.752,2.800 cm,1.192,and 52 years,with the area under the curve values of 0.958,0.865,0.745,0.646,and 0.667,respectively.Kaplan-Meier single factor analysis revealed that the survival times significantly differed among patients with different PV(<12.565 cm3 vs.≥ 12.565 cm3),T/NFLT (<7.752 vs.>7.752),maximum diameter(<2.800 cm vs.>2.800 cm),and T/NFDG values(<l.192 vs.>1.192),as well as different pathologies of the first operation(WHO Ⅱ vs.WHO Ⅲ and Ⅲ) (x2=12.587,12.219,4.285,5.955,6.787;all P<0.05).Cox single-factor analyses indicated that PV,T/NFLT,T/NFDG,and pathology were the risk factors of survival,with the hazard ratios of 0.113(95%CI:0.024-0.530),0.105(95%CI:0.021-0.513),0.314(95%CI:0.109-0.903),and 0.262 (95%CI:0.082-0.838),respectively.Cox multifactor analyses indicated that PV was an independent predictor of survival risk.Conclusion PV is an important factor in the prognosis prediction of patients with recurrent gliomas via 18F-FLT PET/CT imaging.
    • 艾则孜·莫合买提; 沙丽娜; 单莲莲; 阿布力米提·伊力
    • 摘要: 目的 建立HPLC法同时测定新疆贝母中3种核苷类成分的含有量.方法 贝母水提液的分析采用Waters Sun FireTM-C18色谱柱(4.6 mm×150 mm,5μm);流动相甲醇-水(10∶90),等度洗脱;体积流量0.8 mL/min;柱温25°C;检测波长260 nm.结果 尿苷、胸苷、腺苷分别在10.04 ~ 501.93 μg/mL(r=0.997 5)、0.10~5.07 μg/mL(r =0.999 8)、1.01~ 50.39 μg/mL(r=0.999 9)范围内呈良好的线性关系,平均加样回收率分别为103.11%(RSD=1.45%)、99.33% (RSD=1.68%)、98.25% (RSD=1.57%).结论 该方法简便准确,灵敏度高,专属性好,可用于新疆贝母的质量控制.
    • 王朋展; 相美容; 李灿; 巩丽丽; 蒋海强; 吕青涛; 容蓉
    • 摘要: 目的:建立反相高效液相色谱法测定半夏及其主要伪品掌叶半夏、水半夏与天南星中尿嘧啶、胞苷、次黄嘌呤、尿苷、腺嘌呤、次黄嘌呤核苷、鸟苷、胸苷和腺苷含量.方法:采用Diamonsil C18色谱柱(150 mm×4.6 mm,5μm),以水-甲醇为流动相,梯度洗脱,流速0.8 mL· min-1,检测波长262 nm,柱温25°C,进样量50μL.结果:尿嘧啶、胞苷、次黄嘌呤、尿苷、腺嘌呤、次黄嘌呤核苷、鸟苷、胸苷和腺苷质量浓度分别在0.12~5.80 μg· mL-1(r=1.000 0)、0.17~8.40 μg·mL-1(r=0.999 9)、0.17~8.48 μg· mL-1(r=0.999 9)、0.16~8.08 μg· mL-1(r=1.000 0)、0.16~8.16 μg· mL-1(r=0.999 9)、0.15~7.68μg· mL-1(r=0.999 8)、0.16~7.84 μg· mL-1(r=0.999 9)、0.17~8.72 μg· mL-1(r=1.000 0)、0.16~8.24 μg·mL 1(r=0.999 8)范围内线性关系良好;平均加样回收率(n=6)分别为102.31%(RSD=1.08%)、101.67%(RSD=0.33%)、101.77%(RSD=1.37%)、99.24%(RSD=0.85%)、99.98%(RSD=0.73%)、96.73%(RSD=4.05%)、102.11%(RSD=0.47%)、103.56%(RSD=1.97%)、97.01%(RSD=1.62%);不同来源与产地的半夏与其伪品(掌叶半夏、水半夏、天南星)的各核苷含量差别较大,其中胸苷在天南星中未检出.半夏中9种核苷总量在626.7~1 063 μg·g-1之间,掌叶半夏在638.6~1 132 μg·g-1之间,水半夏核苷总量为1076 μg·g-1,天南星为756.2 μg·g-1.结论:本法初步建立了测定半夏及其伪品中9种核苷类成分含量的方法,可用于半夏药材的质量控制.
    • 马赟; 蔡静; 张园娇; 纪乐军; 陈建伟; 李祥
    • 摘要: 目的:建立UFLC-QTRAP-MS/MS的方法,同时测定不同产地绞股蓝及其商品药材中10个化合物(胸苷、尿苷、腺苷、肌苷、2'-脱氧鸟苷、鸟苷、腺嘌呤、次黄嘌呤、尿嘧啶、鸟嘌呤)的含量.方法:采用XBridge Amide色谱柱(2.1 mm×100 mm,3.5 μm),以0.2%甲酸水溶液(A)-0.2%甲酸乙腈溶液(B)为流动相,0.6 mL· min-1流速梯度洗脱,正离子(ESI+)模式下多反应监测(MRM)检测.结果:尿嘧啶、胸苷、尿苷、次黄嘌呤、肌苷、2'-脱氧鸟苷、腺苷、鸟苷、腺嘌呤、鸟嘌呤的线性范围分别为1.97~3 936.00、2.00~200.00、30.48~3 048.00、19.84~1 984.00、10.16~1 016.00、4.95~990.00、19.72~1 972.00、14.70~2 940.00、1.96~196.00、14.76~1 476.00 ng· mL-1(r> 0.997 3),平均加样回收率为99.3%~101.3%,含量分别为181.54~1 604.95、0.00~216.45、63.65~1 093.17、3.48~555.12、0.07~215.66、0.00~171.65、0.00~338.63、24.67~966.08、0.37~140.07、14.89~830.79 μg·g-1,绞股蓝中以尿嘧啶、尿苷、鸟苷、鸟嘌呤含量较高;不同产地及商品药材中10个成分含量有所差异.结论:该方法为绞股蓝药材内在质量的综合评价提供新的科学依据.%Objective:To establish a method for simultaneous determination of 10 components (thymidine,uridine,adenosine,inosine,2'-deoxyguanosine,guanosine,adenine,hypoxanthine,uracil and guanine) in Gynostemma pentaphyllum from different habitats and commercial sources by ultra-fast liquid chromatography tandem combined with triple quadrupole mass spectrometry (UFLC-QTRAP-MS/MS).Methods:The analysis was carried out on an XBridge Amide column (2.1 mm × 100 mm,3.5 μm)which was eluted by a mobile phase of 0.2% formic acid-0.2% formic acid in aeetonitrile at a flow rate of 0.6 mL· min-1.The target compounds were analyzed by the positive ion multiple reaction monitoring (MRM) mode.Results:Uracil,thymidine,uridine,hypoxanthine,inosine,2'-deoxyguanosine,adenosine,guanosine,adenine and guanine showed good linearity(r > 0.997 3)in therange of 1.97-3 936.00 ng· mL-1,2.00-200.00 ng· mL-1,30.48-3 048.00 ng· mL-1,19.84-1 984.00 ng· mL-1,10.16-1 016.00 ng· mL-1,4.95-990.00 ng· mL-1,19.72-1 972.00 ng· mL-1,14.70-2 940.00 ng· mL-1,1.96-196.00 ng· mL-1 and 14.76-1 476.00 ng· mL-1,respectively.The average recoveries of the ten components were between 99.3% and 101.3%.The contents of ten components were in the range of 181.54-1 604.95 μg· g-1,0.00-216.45 μg· g-1,63.65-1 093.17 μg· g-1,3.48-555.12 μg· g-1,0.07-215.66 μg· g-1,0.00-171.6 5 μg· g-1,0.00-338.63 μg· g-1,24.67-966.08 μg· g-1,0.37-140.07 μg· g-1 and 14.89-830.79 μg· g-1,respectively.The contents of uracil,uridine,guanosine and guanine were higher in Gynostemma pentaphyllum.The contents of ten components varied by habitats and commercial sources.Conclusion:The established method provides scientific basis for the comprehensive quality evaluation of Gynostemma pentaphyllum.
    • 刘道佳; 唐明灯; 林端瑜; 张杰平; 李生栩; 蔡志华; 吕清湖; 吴君心
    • 摘要: 目的 比较18F-FDG与18F-FLT PET/CT诊断脑胶质瘤综合治疗后复发的价值.方法 回顾性分析2012年1月至2015年6月因增强MRI发现可疑复发灶在福建省肿瘤医院行18F-FDG与18F-FLT PET/CT显像的20例脑胶质瘤患者(男13例、女7例,年龄12~73岁)资料,所有可疑复发灶均经病理或临床随访证实为脑胶质瘤复发或治疗相关良性病变(TRBC),根据初次手术病理将脑胶质瘤复发分为低级别脑胶质瘤(LGG)复发组和高级别脑胶质瘤(HGG)复发组.对18F-FDG与18F-FLT PET/CT图像进行半定量分析,计算T/NT比值.多组间2种显像剂T/NT比值比较采用单因素方差分析和最小显著差异t检验.通过ROC曲线分析比较18 F-FDG与18F-FLT PET/CT对脑胶质瘤复发的诊断效能.结果 20例患者中14例为脑胶质瘤复发,6例为TRBC.HGG复发组、LGG复发组与TRBC组18F-FDG PET/CT显像的T/NT比值分别为2.31±0.86、1.32±0.86与1.32±0.64,HGG复发组与TRBC组的差异有统计学意义(F=3.671,t=-2.471;P<0.05);HGG复发组、LGG复发组与TRBC组18F-FLT PET/CT显像的T/NT比值分别为8.94±3.14、7.18±3.29与1.92± 1.20,HGG复发组与TRBC组,LGG复发组与TRBC组的差异均有统计学意义(F=13.301,t值:-5.150和-2.360;均P<0.05).ROC曲线分析显示1818F-FDG与18F-FLT T/NT比值鉴别脑胶质瘤复发的最佳阈值分别为1.62和4.58,对应的灵敏度为11/14、13/14,特异性为5/6、6/6,准确性为16/20、19/20,差异均无统计学意义(x2值:1.167、1.091和2.057,均P>0.05).结论 18F-FLT PET/CT显像鉴别脑胶质瘤复发的诊断效能略优于18F-FDG,但差异没有统计学意义.%Objective To compare the diagnostic values of 18F-FDG and 18F-FLT PET/CT in patients with suspicious recurrence of glioma after multimodal treatment.Methods A total of 20 patients (13 males,7 females;age range:12-73 years) with glioma who underwent 18F-FDG and 18F-FLT PET/CT due to abnormal enhancement on MRI from January 2012 to June 2015 were enrolled in this retrospective study.According to the pathological or follow-up results,patients were divided into therapy-related benign changes (TRBC) group and recurrent glioma group,the later was subdivided into initial low-grade glioma (LGG) group and initial high-grade glioma(HGG) group.T/NT ratios of 18F-FDG and 18F-FLT between HGG (LGG) group and TRBC group were compared using one-way analysis of variance and the least significant difference t test.ROC curve analysis was conducted to calculate the differential diagnostic efficiency of 18F-FDG and 18F-FLT between TRBC and recurrent glioma.Results A total of 14 patients were proved as recurrent glioma and 6 patients as TRBC.The mean 18F-FDG T/NT ratios of HGG group,LGG group and TRBC group were 2.31±0.86,1.32±0.86 and 1.32±0.64,respectively.The 18F-FDG T/NT ratio of the HGG group was significantly higher than that of the TRBC group(F=3.671,t=-2.471,P<0.05).The mean 18F-FLT T/NT ratios of HGG group,LGG group and TRBC group were 8.94±3.14,7.18±3.29 and 1.92±1.20,respectively (F=13.301,t values:-5.150 and-2.360,both P<0.05).The optimal T/NT cutoff values for 18 F-FDG and 18F-FLT PET/CT were 1.62 and 4.58,respectively.The sensitivity,specificity and accuracy of detecting recurrent glioma with optimal T/NT cutoff value were 11/14,5/6 and 16/20 for 18F-FDG PET/CT,and those for 18F-FLT PET/CT were 13/14,6/6 and 19/20,respectively.No significant difference was observed between the diagnostic efficiencies of the two imaging modalities (x2 values:1.167,1.091 and 2.057;all P>0.05).Conclusion There were no statistical significances between 18F-FDG and 18F-FLT PET/CT on the differential diagnosis of glioma recurrence.
    • 刘道佳1; 唐明灯1; 林端瑜1; 张杰平1; 李生栩1; 蔡志华1; 吕清湖1; 吴君心2
    • 摘要: 目的比较18F-FDG与18F-FLT PET/CT诊断脑胶质瘤综合治疗后复发的价值。方法回顾性分析2012年1月至2015年6月因增强MRI发现可疑复发灶在福建省肿瘤医院行18F-FDG与18F-FLT PET/CT显像的20例脑胶质瘤患者(男13例、女7例,年龄12~73岁)资料,所有可疑复发灶均经病理或临床随访证实为脑胶质瘤复发或治疗相关良性病变(TRBC),根据初次手术病理将脑胶质瘤复发分为低级别脑胶质瘤(LGG)复发组和高级别脑胶质瘤(HGG)复发组。对18F-FDG与18F-FLT PET/CT图像进行半定量分析,计算T/NT比值。多组间2种显像剂T/NT比值比较采用单因素方差分析和最小显著差异t检验。通过ROC曲线分析比较18F-FDG与18F-FLT PET/CT对脑胶质瘤复发的诊断效能。结果20例患者中14例为脑胶质瘤复发,6例为TRBC。HGG复发组、LGG复发组与TRBC组18F-FDG PET/CT显像的T/NT比值分别为2.31±0.86、1.32±0.86与1.32±0.64,HGG复发组与TRBC组的差异有统计学意义(F=3.671,t=-2.471;P〈0.05);HGG复发组、LGG复发组与TRBC组18F-FLT PET/CT显像的T/NT比值分别为8.94±3.14、7.18±3.29与1.92±1.20,HGG复发组与TRBC组,LGG复发组与TRBC组的差异均有统计学意义(F=13.301,t值:-5.150和-2.360;均P〈0.05)。ROC曲线分析显示,18F-FDG与18F-FLT T/NT比值鉴别脑胶质瘤复发的最佳阈值分别为1.62和4.58,对应的灵敏度为11/14、13/14,特异性为5/6、6/6,准确性为16/20、19/20,差异均无统计学意义(χ2值:1.167、1.091和2.057,均P〉0.05)。结论18F-FLT PET/CT显像鉴别脑胶质瘤复发的诊断效能略优于18F-FDG,但差异没有统计学意义。
    • 王更记; 杨文锋; 付政; 于金明; 穆殿斌
    • 摘要: 目的 探讨NSCLC 18F-FLT PET/CT增殖显像与肿瘤微血管密度(MVD)的相关性.方法 选择2008年1月至2010年12月行手术治疗的NSCLC患者68例,男48例,女20例,年龄36~84岁.术前2周内行18F-FLT PET/CT检查,术后行病理和免疫组织化学细胞增殖核抗原Ki67及CD31、CD34、CD105标记的肿瘤MVD(CD31-MVD、CD34-MVD及CD105-MVD)检测.对SUVmax、Ki67和MVD表达的相关性行直线相关分析.结果 肺癌组织的CD31-MVD、CD34-MVD和CD105-MVD平均值分别为159.6、166.1和38.0个/视野,SUVmax为4.1±2.9,Ki67标记指数(LI)为(37.0±14.5)%;SUVmax、Ki67 LI与CD105-MVD的表达呈正相关(r=0.550和0.633,均P<0.05),但SUVmax与CD31-MVD和CD34-MVD的表达不相关(r=0.228和0.235,均P>0.05).结论 NSCLC 18F-FLT PET/CT显像与CD105-MVD呈正相关,18F-FLT SUVmax可同时反映NSCLC的增殖能力和肿瘤组织的血管增生能力.
    • 王更记; 杨文锋; 付政; 于金明; 穆殿斌
    • 摘要: 目的 探讨NSCLC 18F-FLT PET/CT增殖显像与肿瘤微血管密度(MVD)的相关性.方法 选择2008年1月至2010年12月行手术治疗的NSCLC患者68例,男48例,女20例,年龄36~84岁.术前2周内行18F-FLT PET/CT检查,术后行病理和免疫组织化学细胞增殖核抗原Ki67及CD31、CD34、CD105标记的肿瘤MVD(CD31-MVD、CD34-MVD及CD105-MVD)检测.对SUVmax、Ki67和MVD表达的相关性行直线相关分析.结果 肺癌组织的CD31-MVD、CD34-MVD和CD105-MVD平均值分别为159.6、166.1和38.0个/视野,SUVmax为4.1±2.9,Ki67标记指数(LI)为(37.0±14.5)%;SUVmax、Ki67 LI与CD105-MVD的表达呈正相关(r=0.550和0.633,均P<0.05),但SUVmax与CD31-MVD和CD34-MVD的表达不相关(r=0.228和0.235,均P>0.05).结论 NSCLC 18F-FLT PET/CT显像与CD105-MVD呈正相关,18F-FLT SUVmax可同时反映NSCLC的增殖能力和肿瘤组织的血管增生能力.%Objective To explore the correlation between 18F-FLT SUVmax and intratumoral microvessel density (MVD) in NSCLC patients.Methods From January 2008 to December 2010,68 patients (48males and 20 females; age ranging from 36 to 84 years) with NSCLC underwent 18F-FLT PET/CT followed by surgery within two weeks.Tumor proliferation was evaluated in terms of Ki67 labeling index (LI) with SP.MVD was determined using anti-CD31 mAb (CD31-MVD),anti-CD34 mAb (CD34-MVD) and anti-CD105 mAb (CD105-MVD) for each resected tumor.Linear correlation analysis was used to analyze data.Results The mean values of CD31-MVD,CD34-MVD and CD105-MVD were 159.6,166.1,and 38.0 per view field,respectively.Tumor SUVmax was 4.1±2.9,and Ki67 LI was (37.0± 14.5) %,both of which had significantly correlations with CD105-MVD (r=0.550,0.633 ; both P<0.05),but there was no significant relationship between SUVmax and CD31-MVD,CD34-MVD (r=0.228,0.235; both P>0.05).Conclusion 18F-FLT PET/CT imaging has a positive relationship with CD105-MVD of NSCLC,and it could reflect the ability of tumor angiogenesis.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号